Clinical Trials Logo

Clinical Trial Summary

The goal of this basic science study is to to explore the responsivity of glutamate in the brain of treatment-resistant schizophrenia patients to the drug riluzole. The main aims of the study are: To assess the role of glutamate in treatment-resistant schizophrenia using magnetic resonance spectroscopy. To assess the relationship between glutamate levels and brain structural and functional measures (using: structural MRI; functional MRI (fMRI) and arterial spin labelling (ASL)) at baseline. To assess the relationship between longitudinal change in glutamate levels and brain structural and functional measures. To assess the relationship between longitudinal change in glutamate levels and changes in psychopathology. The researchers will compare the changes with healthy controls and those without treatment-resistant schizophrenia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06270108
Study type Interventional
Source King's College London
Contact James Scott
Phone +44 207 848 0002
Email james.1.scott@kcl.ac.uk
Status Recruiting
Phase Early Phase 1
Start date November 14, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Recruiting NCT02572700 - Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis
Recruiting NCT01888783 - Two Measures of Tactile Acuity in CRPS Type I Patients N/A
Recruiting NCT03741478 - Intranasal Insulin and Olanzapine Study in Healthy Volunteers Phase 1
Completed NCT02919774 - Pomaglumetad Effects on Glutamate Biomarkers Phase 1
Completed NCT01460394 - Normative Data of Brain Network Activation in Adolescents and Young Adults
Completed NCT00771940 - Peripheral Metabolic Effects of Ghrelin Phase 1
Recruiting NCT06068322 - Supramaximal High-Intensity Interval Training in People With and Without Chronic Obstructive Pulmonary Disease N/A
Active, not recruiting NCT02652195 - Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II Phase 2
Withdrawn NCT04320966 - Neurovascular Complications and White Matter Damage in Acquired Anemias
Recruiting NCT05046184 - Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets Phase 2
Completed NCT03134963 - Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study
Completed NCT03081546 - Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease
Completed NCT04085094 - Gender Differences in Renal Functioning and Disease
Completed NCT03520543 - [11C]Yohimbine PET Study of alpha2-AR Phase 1
Recruiting NCT06098612 - PET Imaging Evaluation of [11C]SY08 Early Phase 1
Completed NCT02134951 - Biomarker Assessment of Glutamatergic Target Engagement Phase 4
Active, not recruiting NCT05056610 - Confocal Laser Endomicroscopy to Determine Influence of Food Antigens on Mucosal Integrity N/A
Recruiting NCT05656378 - A Repository to Study Host-Microbiome Interactions in Health and Disease
Recruiting NCT05869968 - SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI